Research

syringe-1884784_640

Anyone taking Plegridy?

Source MS Trust: NICE will be assessing Plegridy to decide whether it should continue to be prescribed by the NHS in England. We’ll be telling NICE why we think it should be an option. If you are taking Plegridy we’d really like to know what you think of it, your experiences good and bad. 

Anyone taking Plegridy? Read More »

study-763571_640

New £1.8m research to explore cognitive screening and rehabilitation in multiple sclerosis

Source University of Nottingham: A new £1.85 million research study led by Professor Roshan das Nair at the Institute of Mental Health aims to develop a new computerised screening tool to detect the “invisible” cognitive impairments that can appear early in the life of a person living with multiple sclerosis (MS).

New £1.8m research to explore cognitive screening and rehabilitation in multiple sclerosis Read More »

ecg-1953179_640

T20K in Good Position to Become Preventive MS Treatment, Cyxone Says

Source Multiple Sclerosis News Today: T20K, Cyxone‘s lead compound for treating multiple sclerosis (MS), seems able to prevent or slow disease progression, according to data from preclinical studies. Based on these findings, the company is confident that T20K might become a prophylactic (preventive) medication for MS in the near future.

T20K in Good Position to Become Preventive MS Treatment, Cyxone Says Read More »

ecg-1953179_640

Continuous Use of Gilenya for Up to 3 Years Can Lead to 50% Drop in Annual Relapse Rates, Real-world Study Says

Source Multiple Sclerosis News Today: Multiple sclerosis (MS) patients who began treatment with Gilenya (fingolimod) and stayed with it continuously showed a more than 50 percent reduction in annual relapse rates, a real-world study following these people for up to three years found.

Continuous Use of Gilenya for Up to 3 Years Can Lead to 50% Drop in Annual Relapse Rates, Real-world Study Says Read More »

neurons-1773922_640

Brain Cells Key to Myelin Grown in Lab and Show Long-Term Survival Essential to Research, Study Reports

Source Multiple Sclerosis News Today: Stem cells tweaked in the laboratory have allowed researchers, reportedly for a first time, to generate and maintain ball-shaped cultures — called spheroids — of human brain cells in 3D that contain oligodendrocytes, the cells that produce myelin, along with neurons and the astrocytes that are essential to nerve cell health. These long-surviving

Brain Cells Key to Myelin Grown in Lab and Show Long-Term Survival Essential to Research, Study Reports Read More »

Scroll to Top